CHANEL is the famous Corporate Investor, which was founded in 1883. The fund was located in Europe if to be more exact in France. The main office of represented Corporate Investor is situated in the Neuilly-sur-seine.
The usual things for fund are deals in the range of 10 - 50 millions dollars. The fund is generally included in 2-6 deals every year. The high activity for fund was in 2019.
Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund. For fund there is no match between the country of its foundation and the country of its the most frequent investments - Finland. Among the most popular portfolio startups of the fund, we may highlight Sulapac. Among the most popular fund investment industries, there are Packaging Services, Chemical.
The standard case for the fund is to invest in rounds with 3-4 partakers. Despite the CHANEL, startups are often financed by Valve Ventures, Tekes, Planvest Oy. The meaningful sponsors for the fund in investment in the same round are Xeraya Capital, Mousse Partners, Lifeline Ventures.
Related Funds
Fund Name | Location |
20/20 HealthCare Partners | Auburndale, Massachusetts, United States |
Apple Tree Partners | New York, New York, United States |
Brain Power | China, Guangdong, Shenzhen |
City National Bank | California, Los Angeles, United States |
CRYSTAL VENTURES | - |
Fairview Health Services | Minneapolis, Minnesota, United States |
Flexible Funding | - |
IDFC Mutual Fund | India, Maharashtra, Mumbai |
J-Ventures | California, Palo Alto, United States |
LS Polaris Innovation Fund | - |
Miteno | Beijing, Beijing, China |
Nazer Group | Jeddah, Makkah, Saudi Arabia |
Octave Life Sciences | - |
PJT Partners | New York, New York, United States |
Surveyor Capital | Chicago, Illinois, United States |
Virginia Tech Carilion (VTC) Innovation Fund | Roanoke, United States, Virginia |
Wattsense Participations | - |
WERU Investment | Chiyoda, Japan |
Yingchuang Dehong | Chengdu, China, Sichuan |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
P2 Science | 23 Feb 2023 | Connecticut, United States | |||
Evolved By Nature | $120M | 28 Jun 2022 | Massachusetts, United States | ||
Evolved By Nature | $70M | 24 Dec 2021 | Massachusetts, United States | ||
Arcaea | $78M | 27 Oct 2021 | Boston, Massachusetts, United States | ||
P2 Science | $12M | 29 Jan 2020 | Connecticut, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
P2 Science | 23 Feb 2023 | Connecticut, United States | |||
Evolved By Nature | $120M | 28 Jun 2022 | Massachusetts, United States | ||
Evolved By Nature | $70M | 24 Dec 2021 | Massachusetts, United States | ||
Arcaea | $78M | 27 Oct 2021 | Boston, Massachusetts, United States | ||
P2 Science | $12M | 29 Jan 2020 | Connecticut, United States |